NUTRIREA-2 (Holden Young - Roseman University College of Pharmacy)HoldenYoung3
NUTRIREA-2 (Holden Young - Roseman University College of Pharmacy)
Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised,
controlled, multicentre, open-label, parallel-group study (NUTRIREA-2).
Lancet. 2018;391:133–43
NUTRIREA-2 (Holden Young - Roseman University College of Pharmacy)HoldenYoung3
Presentation
NUTRIREA-2 (Holden Young - Roseman University College of Pharmacy)
Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised,
controlled, multicentre, open-label, parallel-group study (NUTRIREA-2).
Lancet. 2018;391:133–43
Adequacy of Enteral Nutritional Therapy Offered to Patients in an Intensive C...asclepiuspdfs
Introduction: Malnutrition is a common framework in hospitalized patients. Enteral nutritional therapy (ENT) is the most commonly used strategy to treat malnutrition. However, complications related to ENT can make it impossible to reach the nutritional requirements of the patient. Objectives: The objectives of the study are to evaluate the nutritional status of patients receiving exclusive ENT and to assess the adequacy of ENT in an intensive care unit (ICU). Materials and Methods: Retrospective study conducted in an ICU of a private hospital in Cuiabá/MT/Brazil between 2015 and 2016. The sample consisted of 115 patients >18 years of age in exclusive ENT. The nutritional status was evaluated using anthropometric, clinical, dietary, and biochemical measurements, and it was categorized by the subjective global assessment. The calorie and protein requirements were calculated according to the hospital protocol
PEPTIC (Holden Young - Roseman University College of Pharmacy)HoldenYoung3
PEPTIC (Holden Young - Roseman University College of Pharmacy)
Effect of stress ulcer prophylaxis with proton pump inhibitors vs histamine-2 receptor blockers on in-hospital
mortality among ICU patients receiving invasive mechanical ventilation (PEPTIC).
JAMA . 2020; 323(7):616-626
NUTRIREA-2 (Holden Young - Roseman University College of Pharmacy)HoldenYoung3
NUTRIREA-2 (Holden Young - Roseman University College of Pharmacy)
Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised,
controlled, multicentre, open-label, parallel-group study (NUTRIREA-2).
Lancet. 2018;391:133–43
NUTRIREA-2 (Holden Young - Roseman University College of Pharmacy)HoldenYoung3
Presentation
NUTRIREA-2 (Holden Young - Roseman University College of Pharmacy)
Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised,
controlled, multicentre, open-label, parallel-group study (NUTRIREA-2).
Lancet. 2018;391:133–43
Adequacy of Enteral Nutritional Therapy Offered to Patients in an Intensive C...asclepiuspdfs
Introduction: Malnutrition is a common framework in hospitalized patients. Enteral nutritional therapy (ENT) is the most commonly used strategy to treat malnutrition. However, complications related to ENT can make it impossible to reach the nutritional requirements of the patient. Objectives: The objectives of the study are to evaluate the nutritional status of patients receiving exclusive ENT and to assess the adequacy of ENT in an intensive care unit (ICU). Materials and Methods: Retrospective study conducted in an ICU of a private hospital in Cuiabá/MT/Brazil between 2015 and 2016. The sample consisted of 115 patients >18 years of age in exclusive ENT. The nutritional status was evaluated using anthropometric, clinical, dietary, and biochemical measurements, and it was categorized by the subjective global assessment. The calorie and protein requirements were calculated according to the hospital protocol
PEPTIC (Holden Young - Roseman University College of Pharmacy)HoldenYoung3
PEPTIC (Holden Young - Roseman University College of Pharmacy)
Effect of stress ulcer prophylaxis with proton pump inhibitors vs histamine-2 receptor blockers on in-hospital
mortality among ICU patients receiving invasive mechanical ventilation (PEPTIC).
JAMA . 2020; 323(7):616-626
ATS Symposium: Leukotriene Antagonists As First-line Asthma Controller For St...Zoe Mitchell
ATS Symposium session presented by Prof. David Price:
Leukotriene Antagonists As First-line Asthma Controller For Step 2
Presented May 2015 at ATS 2015, Denver, Colorado, USA
Context—Proton pump inhibitors (PPIs) are among the most commonly used drugs worldwide, and have been linked to acute interstitial nephritis. Less is known about the relationship between PPI use and chronic kidney disease (CKD).
Objective—To quantify the association between PPI use and incident CKD in a population based cohort.
In total, 144,032 participants in Communities study with an estimated glomerular filtration rate of at least 60 mL/min/1.73 m2 were followed from a baseline visit between February 1, 1996, and January 30, 1999, to December 31, 2011. The data was analysed from May 2015 to October 2015.
Dr Alison Young, Consultant Medical Oncology, Leeds Teaching Hospitals Trust
Dr Andrew Stewart, Haematologist and Lead for Acute Oncology, University Hospitals of the North Midlands
Ceri Stubbs, Clinical Lead, Velindre NHS Trust
A SEEMINGLY BENIGN DRUG IN THE SPOTLIGHT: AN EDUCATIONAL INTERVENTION TO REDU...Khushboo Gandhi
INTRODUCTION
Overutilization of Proton pump inhibitors (PPI) in hospitalized patients is a well-recognized problem. In our previous study at St. Luke’s Hospital, we found that the lack of published guidelines for PPI use in non-critically ill patients results in overutilization of PPI in hospitalized patients. We conducted an educational intervention program to address this problem.
DISCUSSION
Overutilization of PPI in non-critically ill hospitalized patients is a known problem in medical practice. Use of PPI has been implicated in number of adverse consequences including but not limited to Clostridium difficile infection, pneumonia, and osteoporosis. In recent studies, PPI was found to be associated with increased in-hospital mortality, increased risk of cardiovascular events, dementia and chronic renal failure (CRF). We studied the magnitude of the problem in our hospital and employed an educational intervention program, which resulted in a significant reduction of inappropriate use of PPI in the hospital.
There were several limitations to our study. This was a retrospective study where we noted a lack of proper documentation for outpatient use of PPI. We also were unable to precisely determine for how long the patients were taking PPI as outpatients. Our intervention included only medical residents (a total of 41), so we excluded data from NPs, hospitalists or PCPs after intervention. As a result, we are unable to determine the effect of the educational intervention on their practice.
CONCLUSION
PPIs have long been considered as relatively harmless drugs. In recent years, it has been implicated in several adverse effects that increases patient morbidity and mortality along with increased healthcare expenditure. Our data shows that proper education and ongoing surveillance, especially during admission and discharge can significantly reduce overutilization of PPI.
How to improve enteral feeding tolerance in chronically critically ill patientsDr Jay Prakash
These interruptions to EN result in significant daily and cumulative calorie deficits, thus contributing to underfeeding and malnutrition. Underfed patients have an increased risk of all-cause mortality, bloodstream infections and longer ICU and hospital stays.
ATS Symposium: Leukotriene Antagonists As First-line Asthma Controller For St...Zoe Mitchell
ATS Symposium session presented by Prof. David Price:
Leukotriene Antagonists As First-line Asthma Controller For Step 2
Presented May 2015 at ATS 2015, Denver, Colorado, USA
Context—Proton pump inhibitors (PPIs) are among the most commonly used drugs worldwide, and have been linked to acute interstitial nephritis. Less is known about the relationship between PPI use and chronic kidney disease (CKD).
Objective—To quantify the association between PPI use and incident CKD in a population based cohort.
In total, 144,032 participants in Communities study with an estimated glomerular filtration rate of at least 60 mL/min/1.73 m2 were followed from a baseline visit between February 1, 1996, and January 30, 1999, to December 31, 2011. The data was analysed from May 2015 to October 2015.
Dr Alison Young, Consultant Medical Oncology, Leeds Teaching Hospitals Trust
Dr Andrew Stewart, Haematologist and Lead for Acute Oncology, University Hospitals of the North Midlands
Ceri Stubbs, Clinical Lead, Velindre NHS Trust
A SEEMINGLY BENIGN DRUG IN THE SPOTLIGHT: AN EDUCATIONAL INTERVENTION TO REDU...Khushboo Gandhi
INTRODUCTION
Overutilization of Proton pump inhibitors (PPI) in hospitalized patients is a well-recognized problem. In our previous study at St. Luke’s Hospital, we found that the lack of published guidelines for PPI use in non-critically ill patients results in overutilization of PPI in hospitalized patients. We conducted an educational intervention program to address this problem.
DISCUSSION
Overutilization of PPI in non-critically ill hospitalized patients is a known problem in medical practice. Use of PPI has been implicated in number of adverse consequences including but not limited to Clostridium difficile infection, pneumonia, and osteoporosis. In recent studies, PPI was found to be associated with increased in-hospital mortality, increased risk of cardiovascular events, dementia and chronic renal failure (CRF). We studied the magnitude of the problem in our hospital and employed an educational intervention program, which resulted in a significant reduction of inappropriate use of PPI in the hospital.
There were several limitations to our study. This was a retrospective study where we noted a lack of proper documentation for outpatient use of PPI. We also were unable to precisely determine for how long the patients were taking PPI as outpatients. Our intervention included only medical residents (a total of 41), so we excluded data from NPs, hospitalists or PCPs after intervention. As a result, we are unable to determine the effect of the educational intervention on their practice.
CONCLUSION
PPIs have long been considered as relatively harmless drugs. In recent years, it has been implicated in several adverse effects that increases patient morbidity and mortality along with increased healthcare expenditure. Our data shows that proper education and ongoing surveillance, especially during admission and discharge can significantly reduce overutilization of PPI.
How to improve enteral feeding tolerance in chronically critically ill patientsDr Jay Prakash
These interruptions to EN result in significant daily and cumulative calorie deficits, thus contributing to underfeeding and malnutrition. Underfed patients have an increased risk of all-cause mortality, bloodstream infections and longer ICU and hospital stays.
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Best Ayurvedic medicine for Gas and IndigestionSwastikAyurveda
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
2. PAGE 1
ACUTE PANCREATITIS
− The incidence of a sudden inflammation of
Pancreas.
− Mortality rates of 80% occur that are due to
complications
− Affects middle-aged adults
Men
women
− Degree of inflammation
Mild edema
Severe hemorrhagic necrosis
− Common Causes
Gallbladder Disease
Chronic alcohol abuse
− Less Common
Abdominal trauma
Viral infections
Duodenal ulcers
PATHOPHYSIOLOGY OF ACUTE PANCREATITIS
Premature activation of trypsin leads to increased pancreatic digestive enzymes.
Results in intrapancreatic inflammation, leading to extra pancreatic inflammation.
Complications
sepsis
multiple organ dysfunction
acute respiratory syndrome
3. PAGE 2
CLINICAL PRESENTATION
Left upper quadrant pain
Abdominal tenderness
Nausea and vomiting
Crackles present in lungs
Decreased or absent bowel sounds
COMPLICATIONS
Pseudocyst
Pancreatic abscess
Pancreatic infection
- 13.5% of mortality rates are due to infection.
CURRENTLY
No standard protocol for providing nutritional support.
Parenteral nutritional support common practice.
High levels of morbidity, cost, complications, and mortality.
CASE SCENERIO
A 35-year-old female patient complaining of sharp epigastric pain
associated with nausea and frequent vomiting. Acute pancreatitis
has been diagnosed. Gallbladder disease, alcohol, drugs and other
common etiologies have been ruled out by history, examination &
investigations.
Which nutritional intervention, enteral or parenteral feeding,
improves dietary intake, results in fewer treatment
complications, and decreases length of hospitalization?
1. ASK THE QUESTION
4. PAGE 3
BACKGROUND QUESTION
What is the diagnostic tests for acute appendicitis and which
is suitable for this case? What is the gold standard for acute
appendicitis? Combination between diagnostic tests and
clinical findings is required for accurate diagnosis of acute
appendicitis.
There is many diagnostic tests including laboratory and
imaging tests.
35% of wrong diagnosis for acute appendicitis result in
appendectomy for normal appendix is accepted percent.
SEARCH STRATEGIES
Text book ,chapters appendices
Guides to diagnostic tests
Selected electronic reference tool for background health
information
BACKGROUND ANSWERS:
Gold Standard is exploratory laparotomy (Histological
result from the surgery). Imaging diagnostic tests is
suitable to decrease negative appendectomy rates. One
Size doesn't fits all rule . Our case is for adult non
complicated patient with high Alvarado score ensure
high possibility to have acute appendicitis. According to
our Scenario and background question answers, we
choose CT scan test to compare with the gold
standard.
5. PAGE 4
2. FORMULATING A FOCUSED QUESTION
PICO QUESTION (TREATMENT)
P – Patients with acute pancreatitis
I – Parenteral feeding
C – Enteral feeding
O – Improves dietary intake resulting fewer treatment
complications, and decreases length of hospitalization.
In adult patients with acute pancreatitis, which nutritional
intervention, enteral or parenteral feeding, improves dietary
intake, results in fewer treatment complications, and decreases
length of hospitalization?
FOREGROUND QUESTION:
“In adult patients with acute pancreatitis, which nutritional
intervention, enteral or parenteral feeding, improves dietary
intake, results in fewer treatment complications, and decreases
length of hospitalization?”
LITERATURE REVIEW
Randomized control trials and 3 meta-analysis were
reviewed to compare patient outcomes.
Databases used:
Ovid
CINAHL
MEDLINE
6. PAGE 5
Cochrane Systematic Reviews
Studies compared:
Nutrition support
Enteral & Parenteral
Complications
Length of stay
Dietary improvement
Cost of care
Screening Methods
APACHE II score
Ranson criteria
Evaluation upon admission and 48 hours after
admission
Algorithms to aid in addressing nutritional support
CHARACTERISTICS OF STUDY PARTICIPANTS
Adults with severe acute pancreatitis
Nutritional Intervention. Which is better?
Parenteral nutrition
Enteral nutrition
APACHE II score > 10
Classify severity of disease in ICU
Measured during the first 24 hours of admission
Point score system
Based on 12 routine physiological measurement
Blood pressure, heart rate, temperature,
respiratory rate etc.
Ranson score > 2
7. PAGE 6
Predict severity of disease & mortality
Uses parameters such as:
Age
White blood cell count at admission
Hematocrit 48 hours after admission
Serum urea nitrogen level 48 hours after
admission
3. EVIDENCE BASED FINDINGS
Dietary Improvement
4.1 fewer days of nutritional support
80% progressed to oral diet without problem
Nutritional level returned to baseline within 24 hours
of enteral nutrition
Maintain gut integrity
Decreased incidence of hyperglycemia
Complications related to parenteral nutrition. What are
complications?
Sepsis
Catheter-related infection
Nosocomial infection
Prolonged starvation leads to bacterial overgrowth
Ileus up to 5 days longer
Length of Stay. Increased or decreased?
Median length of stay reduced by 2.9 days
Cost of Care. Cost effective?
Parenteral vs. Enteral
8. PAGE 7
$2608 vs. $1375
After sensitivity analysis : $2608 vs. $957
In the reviewed studies, evidence showed that patients
receiving enteral nutrition therapy had fewer treatment
complications, experienced dietary improvement, had a
shorter length of hospitalization, and a lower cost of care.
TRAIL
Background: Acute pancreatitis creates a catabolic stress
state promoting a systemic inflammatory response and
nutritional deterioration. Adequate supply of nutrients plays
an important role to ensure optimum recovery. Total
parenteral nutrition (TPN) has been the standard practice
for providing exogenous nutrients to patients with severe
acute pancreatitis. However, recent data suggest that
enteral nutrition (EN) is feasible. Thus, a comparison of EN
and TPN in patients with acute pancreatitis needs to be
made.
Objectives: To compare the effect of total parenteral
nutrition (TPN) versus enteral nutrition (EN) on mortality,
morbidity and length of hospital stay in patient with acute
pancreatitis.
Search strategy: Trials were identified by computerized
searches of The Cochrane Controlled Trials Register,
MEDLINE, and EMBASE. Additional studies were identified
and included where relevant by searching Scisearch, the
bibliographies of review articles and identified trials, and
personal files. The search was undertaken in August, 2000.
No language restrictions were applied.
9. PAGE 8
Selection criteria: Randomized clinical trials, in which
nutrition support with TPN were compared to EN in patients
with acute pancreatitis.
Data collection and analysis: Two reviewers independently
abstracted data and assessed trial quality. Information was
collected on death, length of hospital stay, systemic
infection, local septic complications, and other local
complications.
Main results: Two trials with a total of 70 participants were
included. The relative risk (RR) for death with EN vs TPN was
0.56 (95% CI 0.05 to 5.62). Mean length of hospital stay was
reduced with EN (WMD -2.20, 95% CI -3.62 to -0.78). RR for
systemic infection with EN vs TPN was 0.61 (95% CI 0.29 to
1.28). In one trial, RR for local septic complications and
other local complications with EN vs TPN was 0.56 (95% CI
0.12 to 2.68) and 0.16 (95% CI 0.01 to 2.86) respectively.
Reviewer's conclusions: Although there is a trend
RECOMMENDED PROTOCOL
Identify early predictors of acute pancreatitis by using
reliable scoring systems to indicate severity
Acute Physiology and Chronic Health Evaluation
(APACHE II)
Ranson Criteria
PROPOSED PROTOCOL
Assess patients nutritional status
History of present illness
10. PAGE 9
Physical assessment
Serum levels of protein and albumin
Obtain dietary consult
Insert nasogastric or nasojejunal tube
Initiate enteral nutrition within first 48 hours
Continue enteral nutrition until patient may begin oral
feedings
Advance oral feedings as tolerated
If patient does not tolerate enteral nutrition begin
parenteral nutrition
4. SUGGESTIONS FOR FURTHER STUDY
Increase sample size in future studies
Standardize operational definitions of study outcome
variables so that studies may be compared.
Standardize severity scoring systems in future studies
5. APPLYING THE EVIDENCE
CONCLUSION
The American College of Gastroenterology supports the use
of enteral nutrition
Stabilize the gut barrier function
Prevent complications associated with bacterial
infection
The reviewed studies provided evidence that the use of
enteral nutrition is the choice of nutritional therapy for
patients with acute severe pancreatitis.
11. PAGE 10
Doctors can play an important role in the healthcare team
by influencing the team members to use the appropriate
nutritional intervention in patients with acute severe
pancreatitis.
towards reductions in the adverse outcomes of acute
pancreatitis after administration of EN, clearly there are
insufficient data to draw firm conclusions about the
effectiveness and safety of EN versus TPN. Further trials are
required with sufficient size to account for clinical
heterogeneity and to measure all relevant outcomes.